重症监护设备市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

2024 年全球重症监护设备市场价值为 601 亿美元，预计 2025 年至 2034 年的复合年增长率为 5.5%。这些设备对于处理危及生命的情况至关重要，需要持续监测并立即进行医疗干预。

该领域的常见设备包括用于支持呼吸的呼吸机、用于精确药物管理的输液泵、用于追踪生命体征的病人监护仪、用于心臟病急救的除颤器以及用于肾衰竭患者的透析机。这些产品有助于及时提供护理并改善患者的治疗效果。

市场依产品类型划分，包括去颤器、多参数监测设备、心电图机、血液透析设备、输液帮浦、呼吸器、餵食管、麻醉监视器、CRRT 设备等。其中，除颤器占有最大的份额，到2024年将占22.6%。

在应用方面，市场分为肾臟护理、心臟病学、神经病学和其他领域。心臟病学领域占主导地位，到 2024 年将占 35.8%。这些设备在 ICU 和急救环境中尤其重要，及时介入可以挽救生命。随着对微创和非侵入性心臟治疗的需求不断增长，能够以最小的不适感提供精确资料的先进监测系统变得越来越受欢迎。

美国重症监护设备市场预计将经历显着成长，到 2034 年可能达到 344 亿美元。随着对先进重症监护技术的需求不断增长，投资和收购可能会增强市场的技术能力，最终改善患者的治疗效果并支持该领域的持续成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 重症加护病房需求不断增长
    • 全球慢性病发生率不断上升
    • 重症监护的技术进步
    • 为了更好地管理疾病，对呼吸器的需求激增
  • 产业陷阱与挑战
    • 缺乏熟练的专业人员
    • 重症监护设备成本高昂
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 除颤器
• 多参数监测设备
• 心电图设备
• 血液透析机
• 点滴帮浦
• 呼吸器
• 餵食管
• 麻醉监视器
• CRRT 机器
• 其他产品

第 6 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 肾臟护理
• 心臟病学
• 神经病学
• 其他应用

第 7 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 专科诊所
• 其他最终用途

第 8 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 波兰
  • 奥地利
  • 丹麦
  • 瑞士
  • 荷兰
  • 捷克共和国
  • 瑞典
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 泰国
  • 印尼
  • 越南
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥伦比亚
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 伊朗

第九章：公司简介

• Air Liquide Medical Systems India
• Asahi Kasei Corporation
• B. Braun Melsungen
• Baxter
• Becton, Dickinson and Company
• Boston Scientific corporation
• Cardinal Health
• Drägerwerk
• Fresenius Medical Care
• GE Healthcare
• Getinge
• Hamilton Medical
• ICU Medical
• Koninklijke Philips
• Medtronic

The Global Critical Care Devices Market, valued at USD 60.1 billion in 2024, is expected to grow at a CAGR of 5.5% from 2025 to 2034. Critical care devices are essential medical tools designed to assist and monitor patients in critical health conditions, often within intensive care units (ICUs). These devices are vital for managing life-threatening conditions, requiring constant monitoring and immediate medical intervention.

Common devices in this sector include ventilators for supporting respiration, infusion pumps for accurate medication administration, patient monitors for tracking vital signs, defibrillators used in cardiac emergencies, and dialysis machines for patients with kidney failure. These products help provide timely care and improve patient outcomes.

The market is divided by product type, including defibrillators, multiparameter monitoring devices, ECG machines, hemodialysis equipment, infusion pumps, ventilators, feeding tubes, anesthesia monitors, CRRT devices, and others. Among these, defibrillators hold the largest share, accounting for 22.6% share in 2024. With the aging global population, the need for defibrillators has surged, especially in regions with rapidly increasing elderly populations who are at higher risk for heart-related issues.

In terms of application, the market is segmented into renal care, cardiology, neurology, and other areas. The cardiology segment dominates, with a 35.8% share in 2024. Cardiovascular diseases, including heart attacks and heart failure, are major causes of mortality worldwide, driving the need for critical care devices in cardiology. These devices are particularly crucial in ICU and emergency settings, where timely intervention can be life-saving. As demand for less invasive and non-invasive cardiac treatments grows, advanced monitoring systems capable of delivering precise data with minimal discomfort are becoming more sought after.

U.S. critical care devices market is projected to experience significant growth, potentially reaching USD 34.4 billion by 2034. The U.S. market is expected to benefit from the continued innovation and expansion of product offerings by leading manufacturers. As demand for advanced critical care technologies rises, investments and acquisitions are likely to enhance the technological capabilities of the market, ultimately improving patient outcomes and supporting sustained growth in this sector.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ Synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising demand for intensive care units
    • 3.2.1.2 Growing incidence of chronic diseases throughout the globe
    • 3.2.1.3 Technological advancements in critical care
    • 3.2.1.4 Surging demand for ventilators for better management of diseases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled professionals
    • 3.2.2.2 High cost of critical care devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn and Units)

• 5.1 Key trends
• 5.2 Defibrillators
• 5.3 Multiparameter monitoring devices
• 5.4 ECG devices
• 5.5 Hemodialysis machines
• 5.6 Infusion pumps
• 5.7 Ventilators
• 5.8 Feeding tubes
• 5.9 Anesthesia monitors
• 5.10 CRRT machines
• 5.11 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Renal care
• 6.3 Cardiology
• 6.4 Neurology
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Specialty clinics
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn and Units)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Poland
  • 8.3.7 Austria
  • 8.3.8 Denmark
  • 8.3.9 Switzerland
  • 8.3.10 Netherlands
  • 8.3.11 Czech Republic
  • 8.3.12 Sweden
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Thailand
  • 8.4.7 Indonesia
  • 8.4.8 Vietnam
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Colombia
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Iran

Chapter 9 Company Profiles

• 9.1 Air Liquide Medical Systems India
• 9.2 Asahi Kasei Corporation
• 9.3 B. Braun Melsungen
• 9.4 Baxter
• 9.5 Becton, Dickinson and Company
• 9.6 Boston Scientific corporation
• 9.7 Cardinal Health
• 9.8 Drägerwerk
• 9.9 Fresenius Medical Care
• 9.10 GE Healthcare
• 9.11 Getinge
• 9.12 Hamilton Medical
• 9.13 ICU Medical
• 9.14 Koninklijke Philips
• 9.15 Medtronic